igeahub.com
Immuno-Oncology Upcoming Immunotherapies - IgeaHub
February 9, 2016 Phase 1 Study of Second Generation Non-Viral CD19-Specific CAR T-Cell Therapy for Advanced Lymphoid Malignancies ZIOPHARM Oncology, a